Bacteria therapy shows promise for eczema
Topical treatment with live Roseomonas mucosa was found to be safe for adults and children with atopic dermatitis...
List view / Grid view
Topical treatment with live Roseomonas mucosa was found to be safe for adults and children with atopic dermatitis...
Researchers have found that the FDA-approved anti-inflammatory drug Celecoxib had beneficial effects on the muscle function in muscular dystrophy...
Researchers have discovered that an enzyme called UGT8 drives the progression of basal-like breast cancer...
Non-aspirin non-steroidal anti-inflammatory medications have been found to have a negative impact on overall and progression-free survival time for mRCC patients...
The breast cancer drug lapatinib which is designed to shrink tumours can sometimes cause them to grow in the lab...
The FDA has approved Tafinlar in combination with Mekinist for the adjuvant treatment of patients with melanoma with BRAF V600E or V600K mutation...
30 April 2018 | By Vaisala
The 2017 revision to ISO/IEC 17025 includes better guidance on conformity and a new risk-based approach. In this webinar we discuss the revision in terms of temperature and humidity calibration in life science environments...
A test of 55 antiviral drugs that are known to be safe in humans found 7 compounds that show new effects against multiple viruses...
The mismatch between two MRI methods could signify early stroke status, allowing the use of 'clot-busting' drug...
Long-term use of some anticholinergic medications are associated with an increased risk of dementia – according to a new study led by the University of East Anglia...
B&W Tek is proud to announce the QTRam™ for nondestructive and real-time pharmaceutical content and blend uniformity measurement powered by the award-winning STRaman™ technology at CPhI North America on Tuesday, April 24, 2018...
The FDA has announced its latest action to encourage and support the development of treatment options for people with opioid use disorder...
Mount Sinai shows the potential link between Parkinson's disease and inflammatory bowel disease, suggests anti-TNFα therapy may reduce the risk of developing Parkinson's...
The FDA has approved Crysvita, the first drug approved to treat adults and children ages 1 year and older with x-linked hypophosphatemia, a rare, inherited form of rickets...
One class of drug used to treat type 2 diabetes may not reduce the risk of death when compared with placebo, suggests new findings...